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do not affect other isoforms are demanded. N~°-Monomethyl- 
Abstract We have found three novel quinazolidine derivatives 
which inhibit the formation of nitrite dose-dependently in a L-arginine (L-NMMA), aminoguanidine and S-ethylisothio- 
murine macrophage cell line, RAW264.7. The decreased nitrite urea are potent inhibitors of NOS II activity [3-5]. However, 
formation was due not to the inhibition of nitric oxide synthase most NOS inhibitors including three were designed to mimic 
activity but to suppression of NOS II mRNA and protein the substrate L-arginine or the product L-citrulline, and are 
expression. In rat vascular smooth muscle cells (VSMC), therefore not totally specific for NOS II. On the other hand, 
however, these compounds rather enhanced NOS II mRNA. it has been confirmed that glucocorticoids and transforming 
These compounds also prevented LPS-stimulated heme oxy- growth factor (TGF)-~I inhibited NOS II expression i  many 
genase-1 (HO-1) and cyclooxygenase-2 (COX-2) gene expres- cellular systems [6,7]. Thus it may become a useful approach 
sion in RAW264.7 cells, but again not in VSMC. The three to establish compounds which inhibit the induction of a spe- 
quinazolidine derivatives pecifically inhibit gene expression of cific gene(s) during inflammation. 
NOS II, HO-I and COX-2 only in macrophage cells, indicating 
that they are selective inhibitors of inducible gene expression in Here we report three novel compounds which inhibit the 
macrophages, nitrite formation in a murine macrophage cell line, 
RAW264.7, without affecting NOS II activity. The mechanism 
Key words: Nitric oxide; Nitric oxide synthase; is likely to be related to the inhibition of NOS II gene tran- 
Cyclooxygenase; Heme oxygenase; Gene expression scription in RAW264.7 cells. Moreover, they prevented the 
LPS-stimulated HO-1 and COX-2 mRNA expression in 
RAW264.7 cells, whereas they enhanced NOS II and COX- 
1. Introduction 2 induction and had no effect on HO-1 mRNA expression i  
VSMC. 
Many types of cells produce nitric oxide (NO) by oxidizing 
L-arginine with molecular oxygen [1]. Three NO synthase 2. Materials and methods 
(NOS) isoforms have been identified and cloned [2]. One 
form, constitutively expressed mainly in the brain (NOS I), L-[U-14C]Arginine monohydrocbloride (319 mCi/mmol) and [c~- 
is Ca2+-dependent, but the inducible form (NOS II) found in 32p]dCTP were obtained from Amersham Corp. NADPH was ob- 
macrophages, mooth muscle cells and hepatocytes i  Ca 2+- tained from Oriental Yeast. Tetrahydrobiopterin was from Wako 
independent. The other form of NOS (NOS II[), associated Pure Chemical Industries. Dowex 50W-X8 was obtained from Muro- 
machi Kagaku Kogyo. A monoclonal ntibody raised against mouse 
with membranes, i  expressed mainly in endothelial cells. NO NOS II was obtained from Transduction Laboratories. Recombinant 
produced by NOS III is essential for controlling endothelial IL-lO (specific activity 20 U/ng protein) was kindly supplied by Otsu- 
functions in the cardiovascular system. NOS I functions in ka Pharmaceutical Co., Ltd. Other reagents were of the highest grade 
neuronal transmission under physiological conditions. On available. 
the other hand, macrophages and smooth muscle cells acti- 
2.1. Assaying of nitrite produced by RA W264. 7cells 
vated by cytokines and lipopolysaccharide (LPS) release a RAW264.7 cells, a mouse macrophage-like c ll line transformed 
large amount of NO, which plays a key role in the pathophys- with the Abelson leukemia virus, obtained from the American Type 
iology of a variety of diseases, including sepsis and inflamma- Culture Collection, were cultured in Dulbecco's modified Eagle's ruc- 
tion. dium, containing 4.5 g/1 glucose, 100 units/ml of penicillin and 100 lag/ 
Because NO is produced by NOS II in large amounts and ml of streptomycin, supplemented with 10% heat-inactivated fetal 
bovine serum (Gibco/BRL) at 37°C under an atmosphere of 95% 
damages tissues, inhibitors which are specific to NOS II but air and 5% CO2. 5 × 105 cells/ml/well of 12-well plates were incubated 
for 18 h in medium supplemented with 10 ng/ml LPS and varying 
*Corresponding author. Fax: (81) (6) 879-3429. concentrations of a compound issolved in dimethylsulfoxide. In con- 
E-mail: proftani@biochem.med.osaka-u.ac.jp trol experiments, 0.05% dimethylsulfoxide was always included as a 
vehicle. Following incubation, itrite in the medium was quantitated 
Abbreviations." NO, nitric oxide; NOS, NO synthase; NOS I, brain using the Griess reagent as described [8]. This method, which detects 
NOS; NOS II, macrophage NOS; NOS III, endothelial NOS; DIQ, 4- only nitrite in the medium, was not affected by compounds used in 
(1,1-dimethyl- 1,2-methoxy-ethylamino)-2-(imidazol- 1-yl)-quinazoline this work. 
dihydrochloride; IMT, 2-(imidazol-l-yl)-4-(2-methoxyethylamino)- 
5,6,7,8-tetrahydroquinazoline dihydrochloride; IPE, 2-{2-[2-(imida- 2.2. Assaying of nitrite produced by VSMC 
zol-1-yl)-5-methylthieno[2,3-d]pyrimidine-4-ylamino]ethoxy} ethanol VSMC isolated from rat aorta were cultured in Dulbecco's modified 
dihydrochloride; LPS, lipopolysaccharide; L-NMMA, N~°-mono- Eagle's medium, containing 100 units/ml of penicillin and 100 lag/ml 
methyl-L-arginine; TBS, Tris-buffered saline; VSMC, vascular smooth of streptomycin, supplemented with 20% heat-inactivated f tal bovine 
muscle cells; SSC, standard saline citrate; IL-1 ~, interleukin-l[3 serum (Gibco/BRL) at 37°C under an atmosphere of 95% air and 5% 
0014-5793196l$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
P I IS0014-5793(96)01058-7  
300 N. Fujiwara et al./FEBS Letters 395 (1996) 299-303 
CO2. 1 × 105 cells/ml/well of 12-well plates were incubated for 24 h The extent of inhibition by L -NMMA remained the same and 
with 10 ng/ml IL-I~ and a compound. After incubation, nitrite was did not depend on the time after administration. 
quantitated. To determine whether or not the inhibition of nitrite pro- 
2.3. Assaying of NOS activity duction was due to the direct action of these compounds on 
After stimulation with 10 ng/ml LPS for 24 h, RAW264.7 cells were the NOS II enzyme, we examined their effects on L-[U- 
sonicated and the supernatant was used for the NOS assay. NOS 14C]citrulline formation from L-[U-a4C]arginine using cellular 
activity was determined by assessing the conversion of L-[U- 
14C]arginine to L-[UJ4C]citrulline in the presence of 1 mM EGTA extracts of LPS-stimulated RAW264.7 cells. These corn- 
by the method escribed previously [9]. pounds had no substantial effect on the NOS II activity in a 
cell-free system, while L -NMMA inhibited NOS II activity 
2.4. RNA preparation and Northern analysis dose-dependently, as reported, at all concentrations (data 
After incubation with LPS or IL-113 in the presence of an inhibitor, not shown), indicating that the target molecule of these corn- 
total RNA was prepared from RAW264.7 cells and VSMC in 10-cm 
dishes [10], and quantitated by measuring the absorbance at260 nm. pounds was not the NOS II protein itself. 
20 lag of total RNA was electrophoresed on an 1%, agarose gel con- Since the data described above suggest that the inhibition of 
taining 2.2 M formaldehyde, transferred to a Zeta-Probe membrane, NO production by RAW264.7 cells occurs at the level of NOS 
and then hybridized with a 32p-labeled NOS II cDNA probe [11] at II expression, we examined whether or not they inhibited 
42°C in the presence of 50% formamide. Then it was washed twice at NOS II mRNA expression by Northern blot analysis. As 55°C with 2 × standard saline citrate (SSC) and 0.1% SDS for 30 min, 
and then twice at high stringency with 0.3 x SSC and 0.1% SDS for 30 shown in Fig. 3, they suppressed the level of NOS II 
rain at 65°C. Kodak XAR films were exposed for 1 3 days with an mRNA in RAW264.7 cells in a dose-dependent manner. 
intensifying screen at -80°C. The blots were stripped by boiling in However, the extent of the inhibition was low compared to 
0.1% SDS and 0.1xSSC, and reprobed with COX-2 [12] and HO-1 in the control and was not totally consistent with that of 
[13] cDNA probes serially using the hybridization and washing con- 
ditions given above, nitrite production, as shown in Fig. 2. Thus, the inhibitory 
effects of these compounds on nitrite production cannot be 
2.5. Western blot analysis explained solely by inhibition of transcription of the NOS II 
Protein from RAW264.7 cells (20 lag) incubated with 10 ng/ml LPS gene. Then we examined the level of the NOS II protein in 
in the presence of an inhibitor was subjected to 7.5% SDS-polyacryl- 
amide gel electrophoresis and then transferred to a nitrocellulose RAW264.7 cells at 24 h after stimulation with LPS in the 
membrane under semi-dry conditions with the use of a Semiphor presence of 5 or 50 ~tM each inhibitor. Immunoblot analysis 
TE-70 semi-dry transfer unit (Hoefer). After blocking by incubation indicated that the levels of NOS II protein were suppressed to 
with 4% skim milk in TBS for 12 h at 4°C, the membrane was washed a similar extent to NOS II mRNA in the presence of the 
four times with TBS and 0.05% Tween 20, and then incubated with an inhibitors (Fig. 4). Taken together, all these data suggest 
antibody against mouse NOS II at a 1:2500 dilution for 2 h. After 
washing, the membrane was incubated with peroxidase-conjugated 
goat anti-mouse IgG (Organon Teknika Corp.) for 2 h. A chemilu- H~C,~,~H3 
minescence method involving an ECL kit (Amersham) was employed 
to detect he peroxidase activity. N f "  vOUcH3 ~ ~ 
3. Results a compounds, were DIQ / -%,  
We have screened series of which devel- ~- \ \  
oped as inhibitors of phosphodiesterase types IV and V, by ~ 
N x  
assessing their inhibitory effects on nitrite production by LPS- 
stimulated RAW264.7 cells. On this screening, we found that 
three novel quinazolidine derivatives, 4-(l, l-dimethyl-l ,2- 
methoxy-ethylamino)-2-(imidazol-l-yl)-quinazoline dihydro- ~ /o  "-~H3 
chloride (DIQ), 2-(imidazol-l-yl)-4-(2-methoxyethylamino)- ~ N ~  v 
5,6,7,8-tetrahydroquinazoline dihydrochloride (IMT), and ~ / ' "  ~ 
2-{2-[2-(imidazol- 1-yl)-5-methylthieno[2,3-d]pyrimidine-4-yl- N 
amino]ethoxy}ethanol dihydrochloride (IPE), effectively in- I MT 
hibited nitrite production. Their chemical structures are ~ J~ 
shown in Fig. 1. These compounds at 50 txM did not affect ~ /~ 
cellular viability, as assessed by monitoring the mitochondrial 
reduction of tetrazolium to formazan (data not shown), indi- 
cating that they were not cytotoxic at these concentrations. 
The effects of these compounds and a widely used inhibitor, 
L-NMMA, on LPS-induced nitrite production by RAW264.7 
cells are shown in Fig. 2. Essentially the same inhibition pat- H v ~-" " ~ ~ ° o  
terns were observed when the cells were stimulated with inter- ~ C H 3  N H 
feron-y (data not shown). All three compounds inhibited ni- ~ ~  j l~ .  
trite production dose-dependently. DIQ and IPE inhibited [PE  N 
more than 95% of the nitrite production at 50 ~tM. However, 
the inhibitory effects did not essentially change when they -- \ \  
were administered at 4 h after stimulation with LPS, while - -~_ /P  
they exhibited significantly reduced inhibitory effects when 
administered at 12 h after LPS treatment (data not shown). Fig. 1. Structures of the compounds used. 
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.01 .1 1 10 100 RAW264.7 cells stimulated with LPS. Total RNA was extracted 
Concentration (pM) from RAW264.7 cells stimulated with LPS in the presence of inhibi- 
tors (5 or 50 I.tM) for 18 h. Northern blot analysis was carried out 
Fig. 2. Dose-response curves of nitrite production by RAW264.7 using a mouse NOS II cDNA fragment as a probe. 
cells stimulated with LPS. RAW264.7 cells, 5 × 105/ml/well, were in- 
cubated with 10 ng/ml LPS in the presence of varying concentra- 
tions of inhibitors for 18 h. Nitrite in the conditioned medium was 
quantitated, that in the control experiment being taken as 100%. region of the promoter in mediation of the response to LPS 
Each point indicates the mean + S.D. for triplicate xperiments, is downstream of the NF-~cB site [15] and an IRF-1 binding 
site in macrophages stimulated by IFN- 7 or LPS [16]. On the 
that these reagents inhibited nitrite production through sup- other hand, it was reported that an upstream NF-~B site is of 
pression of NOS II gene expression in RAW264.7 cells, key importance in mediating the synergistic effect of cytokines 
We also examined the effects of these inhibitors on the on NOS II gene activity within VSMC [17]. We examined the 
nitrite production in VSMC, which are another type of cells effects of these compounds on the binding of NF-~B to the 
expressing NOS II by IL-1IL As shown Fig. 5, their effects on reported responsive lements in the gene by means of a gel 
the nitrite production in VSMC were complicated because shift assay, but they did not affect the binding (data not 
they did not inhibit or only slightly enhanced nitrite produc- shown). 
tion at low concentrations, but inhibited it at higher concen- On the other hand, we obtained the opposite results for 
trations. Expression of NOS II mRNA was enhanced dose- VSMC, i.e. the inhibitors enhanced nitrite production and 
dependently by them. We studied the effects of three inhibi- NOS II mRNA.  The discrepancy between nitrite production 
tors on the expression of another two inflammation-associated and NOS II mRNA levels may be explained as follows. While 
enzymes in RAW264.7 cells and VSMC to determine whether nitrite accumulates in the medium during incubation, NOS II 
or not the effects were specific to the NOS II gene. As shown mRNA turns over rapidly. In addition, when we observed 
in Fig. 6, they inhibited HO-1 and COX-2 mRNA in effects of these compounds on the levels of NOS II mRNA 
RAW264.7 cells in the same manner as the NOS II gene, 
but enhanced COX-2 mRNA expression in VSMC, as found RAW 264.7  cel ls  
for NOS II mRNA.  However, they had no effect on HO-1 
mRNA in VSMC except for IMT, which slightly enhanced 
HO-1 mRNA at 50/aM. kPS (10 ng/ml) 
LPS DIQ IMT IPE 
4. Discuss ion (') 0 ~ ~ 
We found three novel compounds which inhibited NO pro- 
duction by macrophages timulated with interferon- 7 and N 
LPS, and investigated the mechanism underlying the inhibi- ~:~:~ @~ 
tion. These compounds ignificantly inhibited nitrite produc- 
~ 4-130 kD tion at micromolar concentrations in RAW264.7 cells, but ~, ~.~ 
had no direct effect on the NOS activity, as judged by assay- : ~ ,  
ing the conversion of L-arginine to L-citrulline. They partially 
reduced the level of NOS I] mRNA as well as that of protein. 
Thus it was likely that these compounds regulated the NOS II 
expression at the level of gene induction. Fig. 4. Effects of inhibitors on NOS II protein expression. 
RAW264,7 cells were stimulated under the same conditions as in Recent studies have shown that the promoter egion of the Fig. 3 for 24 h. After sonication and centrifugation, 20 gg of the 
NOS II gene contains numerous potential sites for the binding soluble protein from the cells was analyzed by Western blotting 
of a number of different transcription factors [14]. A key using an anti-mouse NOS II antibody. 
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Fig. 5. A: Effects of the inhibitors on nitrite production in VSMC stimulated with lL-1[i VSMC, l X 105 cells/ml/well, were incubated with 10 
ng/ml IL-1[~ in the presence of varying concentrations of inhibitors for 24 h. Nitrite in the conditioned medium was quantitated, that in the 
control experiment being taken as 100%. Each point indicates the mean + S.D. for triplicate experiments. B: Effects of inhibitors on NOS II 
mRNA expression in VSMC stimulated with IL-l[3. Northern blot analysis of total RNA prepared from VSMC under the same conditions as 
in A was carried out as described in the legend to Fig. 3. 
at different time points, more mRNA accumulated at 24 h arachidonic acid to prostaglandins. COX-2 but not COX-1 
than at shorter incubation times (data not shown). We re- is induced in a number of cells by proinflammatory stimuli 
cently obtained similar results showing that high levels of and is involved in various types of inflammation. The inhibi- 
cAMP prevented the induction of NOS II mRNA and NO tors suppressed the expression of all these enzymes in macro- 
production in macrophages, but enhanced NOS II mRNA phages, but increased COX-2 mRNA expression in VSMC. 
and NO formation in VSMC (manuscript in preparation). They had no effect on the expression of HO-1 in VSMC. 
Since the inhibitors used in this study were phosphodiesterase The functions of these inhibitors are likely to be related to 
types IV and V inhibitors, in order to examine the possibility the transcription of the genes, although we could not identify 
that the cAMP level may be altered by the inhibitors, we the target molecule involved in their action. Identification of 
measured the cAMP contents 30 min after treatment with the target molecule would also provide us with useful infor- 
the inhibitors. However, no change was observed in either mation about the differential responses of these inducible 
RAW264.7 cells or VSMC (data not shown), genes in macrophages and VSMC. Moreover, these quinazo- 
For further characterization of their action, we examined line derivatives may shed new insight for the development of 
the expression of two other genes involved in inflammation, selective inhibitors of inducible gene expression under inflam- 
HO catalyzes the first and rate-limiting step in the oxidative mation in tissues. 
degradation of heme to bilirubin [18]. Among the two iso- 
forms, HO-1 is induced by inflammatory cytokines, LPS Acknowledgements: This work was supported in parts by Grants-in- 
and other stimulants. COX is the enzyme which converts Aid from the Ministry of Health and Welfare, Japan. 
(A) RAW 264.7 cells (R) V S M C 
LPS (10 ng/ml) I L- 1~ (10 ng/ml) 
LPS DIQ tMT IPE I L- 113 DIQ IMT IPE 
(I o (I o rT--  
HO-1 
iiii~%iiiili~iiiill ii~:!;: ii!il ii! :iilJi ~i~ ii~iii~!i~!iiiii i;;~iiiiil; i!iil ili~!~i i~iiii~i ~i~iii!!i~i;iiii!i;i!~iiiii i i ll ! i~i~i;~ilil ii  ~il ii iii!i!~;; 
COXo2 
Fig. 6. Effects of inhibitors on HO-I and COX-2 expression in RAW264.7 cells and VSMC. The same membranes as in Figs. 3 and 5B were 
dehybridized and then rehybridized with HO-1 and COX-2 cDNAs as probes. 
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